The Commission may consult the relevant scientific committee(s) when establishing the technical requirements referred to in Article 29 and when adapting the technical requirements set out in Annexes I to IV to scientific and technical progress, in particular with a view to ensuring an equivalent level of quality and safety of blood and blood components used for transfusion and blood and blood components used as a starting material for the manufacture of medicinal products.
Art. 30 Directive (EU) 2002/98
Consultation of scientific committee(s)
In forcesince 7 Aug 2009
Changed on 7 Aug 2009
Consultation of scientific committee(s)
- 7 Aug 2009 – todayin force
- 27 Jan 2003 – 7 Aug 2009earlier wording
Versions are held from 27 Jan 2003; the article may be older.